LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program

Currow, D

Chessari, S Bonomi, P Giorgino, R Skipworth, R

Permalink

Closed Access

	Filename	Description	Size
	PIIS092375342304262X.pdf	Published version	89.7 kB	Adobe PDF	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Currow, D https://orcid.org/0000-0003-1988-1250
dc.contributor.author	Chessari, S
dc.contributor.author	Bonomi, P
dc.contributor.author	Giorgino, R
dc.contributor.author	Skipworth, R
dc.date.accessioned	2023-11-10T04:27:55Z
dc.date.available	2023-11-10T04:27:55Z
dc.date.issued	2023-10
dc.identifier.citation	Annals of Oncology, 2023, 34, pp. s1335
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/10453/173330
dc.language	en
dc.publisher	Elsevier
dc.relation.ispartof	Annals of Oncology
dc.relation.isbasedon	10.1016/j.annonc.2023.10.098
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1112 Oncology and Carcinogenesis
dc.subject.classification	Oncology & Carcinogenesis
dc.subject.classification	3202 Clinical sciences
dc.subject.classification	3211 Oncology and carcinogenesis
dc.title	LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program
dc.type	Journal Article
utslib.citation.volume	34
utslib.for	1112 Oncology and Carcinogenesis
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access	*
dc.date.updated	2023-11-10T04:27:53Z
pubs.publication-status	Published
pubs.volume	34

Please use this identifier to cite or link to this item: